Towards a European health research and innovation cloud (HRIC).


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
19 02 2020
Historique:
received: 06 02 2019
accepted: 29 01 2020
entrez: 21 2 2020
pubmed: 23 2 2020
medline: 5 1 2021
Statut: epublish

Résumé

The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this environment should enable data sharing and analysis for health research across the EU, in compliance with data protection legislation while preserving the full trust of the participants. Such a HRIC should learn from and build on existing data infrastructures, integrate best practices, and focus on the concrete needs of the community in terms of technologies, governance, management, regulation, and ethics requirements. Here, we describe the vision and expected benefits of digital data sharing in health research activities and present a roadmap that fosters the opportunities while answering the challenges of implementing a HRIC. For this, we put forward five specific recommendations and action points to ensure that a European HRIC: i) is built on established standards and guidelines, providing cloud technologies through an open and decentralized infrastructure; ii) is developed and certified to the highest standards of interoperability and data security that can be trusted by all stakeholders; iii) is supported by a robust ethical and legal framework that is compliant with the EU General Data Protection Regulation (GDPR); iv) establishes a proper environment for the training of new generations of data and medical scientists; and v) stimulates research and innovation in transnational collaborations through public and private initiatives and partnerships funded by the EU through Horizon 2020 and Horizon Europe.

Identifiants

pubmed: 32075696
doi: 10.1186/s13073-020-0713-z
pii: 10.1186/s13073-020-0713-z
pmc: PMC7029532
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Références

Health Inf Sci Syst. 2014 Jun 30;2:4
pubmed: 25825668
Front Physiol. 2010 Dec 03;1:147
pubmed: 21423387
Inquiry. 2017 Jan;54:46958016685836
pubmed: 28112020
Eur J Hum Genet. 2018 Jun;26(6):778-785
pubmed: 29487416
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Sci Eng Ethics. 2017 Feb;23(1):21-39
pubmed: 26886482
Clin Neuropsychol. 2019 Feb;33(2):287-304
pubmed: 30513257
Comput Struct Biotechnol J. 2019 Feb 08;17:229-240
pubmed: 30847041
Biomed Res Int. 2013;2013:658925
pubmed: 23586054
Genome Med. 2016 Jun 23;8(1):71
pubmed: 27338147
J Am Med Inform Assoc. 2019 Jul 1;26(7):637-645
pubmed: 30925587
Neuron. 2019 Feb 6;101(3):380-384
pubmed: 30731062
NPJ Syst Biol Appl. 2018 Jun 2;4:21
pubmed: 29872544
ScientificWorldJournal. 2014;2014:712826
pubmed: 25136682
J Biomol Struct Dyn. 2016 Dec;34(12):2688-2697
pubmed: 26646249
Nat Rev Genet. 2019 Nov;20(11):693-701
pubmed: 31455890
Genome Med. 2017 Jun 20;9(1):58
pubmed: 28633659
Nat Rev Genet. 2018 May;19(5):325
pubmed: 29430012
PLoS Comput Biol. 2018 Jun 14;14(6):e1006144
pubmed: 29902176
BioData Min. 2018 Nov 12;11:26
pubmed: 30459848
Nature. 2020 Feb;578(7793):31-33
pubmed: 32025008
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
J Med Internet Res. 2011 Sep 21;13(3):e67
pubmed: 21937354
Immunol Rev. 2018 Jul;284(1):24-41
pubmed: 29944754
Brief Bioinform. 2019 Mar 25;20(2):659-670
pubmed: 29688273

Auteurs

F M Aarestrup (FM)

Technical University of Denmark, Kongens Lyngby, Denmark.

A Albeyatti (A)

Medicalchain, York Road, London, SQ1 7NQ, UK.
National Health Service, London, UK.

W J Armitage (WJ)

Translation Health Sciences, Bristol Medical School, Bristol, BS81UD, UK.

C Auffray (C)

European Institute for Systems Biology and Medicine (EISBM), Vourles, France. cauffray@eisbm.org.

L Augello (L)

Regional Agency for Innovation & Procurement (ARIA), Welfare Services Division, Lombardy, Milan, Italy.

R Balling (R)

Luxembourg Centre for Systems Biomedicine, Campus Belval, University of Luxembourg, Luxembourg City, Luxembourg.

N Benhabiles (N)

CEA, French Atomic Energy and Alternative Energy Commission, Direction de la Recherche Fondamentale, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France. nora.benhabiles@cea.fr.

G Bertolini (G)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

J G Bjaalie (JG)

Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

M Black (M)

Ulster University, Belfast, BT15 1ED, UK.

N Blomberg (N)

ELIXIR, Welcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK. niklas.blomberg@elixir-europe.org.

P Bogaert (P)

Sciensano, Brussels, Belgium and Tilburg University, Tilburg, The Netherlands.

M Bubak (M)

Department of Computer Science and Academic Computing Center Cyfronet, Akademia Gornizco Hutnizca University of Science and Technology, Krakow, Poland.

B Claerhout (B)

Ghent University, Ghent, Belgium.

L Clarke (L)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.

B De Meulder (B)

European Institute for Systems Biology and Medicine (EISBM), Vourles, France.

G D'Errico (G)

Fondazione Toscana Life Sciences, 53100, Siena, Italy.

A Di Meglio (A)

CERN, European Organization for Nuclear Research, Meyrin, Switzerland.

N Forgo (N)

University of Vienna, Vienna, Austria.

C Gans-Combe (C)

INSEEC School of Business & Economics, Paris, France.

A E Gray (AE)

PwC, Dronning Eufemiasgate, N-0191, Oslo, Norway.

I Gut (I)

Center for Genomic Regulations, Barcelona, Spain.

A Gyllenberg (A)

Neuroimmunology Unit, The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

G Hemmrich-Stanisak (G)

Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

L Hjorth (L)

Department of Clinical Sciences, Pediatrics, Lund University, Skåne University Hospital, Lund, Sweden.

Y Ioannidis (Y)

Athena Research & Innovation Center and University of Athens, Athens, Greece.

S Jarmalaite (S)

National Cancer Institute, Vilnius, Lithuania.

A Kel (A)

geneXplain GmbH, Wolfenbüttel, Germany.

F Kherif (F)

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

J O Korbel (JO)

European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany. korbel@embl.de.

C Larue (C)

Integrated Biobank of Luxembourg, Rue Louis Rech, L-3555, Dudelange, Luxembourg.

A Maas (A)

Antwerp University Hospital and University of Antwerp, Edegem, Belgium.

L Magalhaes (L)

Clinerion Ltd, Elisabethenanlage, 4051, Basel, Switzerland.

I Manneh-Vangramberen (I)

European Cancer Patient Coalition, Rue de Montoyer/Montoyerstraat, B-1000, Brussels, Belgium.

E Morley-Fletcher (E)

Lynkeus, Via Livenza, 00198, Rome, Italy.
Public Policy Consultant, Rome, Italy.

C Ohmann (C)

European Clinical Research Infrastructure Network, Heinrich-Heine-Universität, Düsseldorf, Germany.

P Oksvold (P)

Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.

N P Oxtoby (NP)

Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.

I Perseil (I)

Information Technology Department, Institut National de la Santé et de la Recherche Médicale, Paris, France.

V Pezoulas (V)

Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece.

O Riess (O)

Institute of Medical Genetics and Applied Genomics, Rare Disease Center, Tübingen, Germany.

H Riper (H)

Section Clinical, Neuro and Developmental Psychology, Department of Behavioural and Movement Sciences, Vrije Universiteit, Amsterdam, The Netherlands.

J Roca (J)

Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.

P Rosenstiel (P)

Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

P Sabatier (P)

French National Centre for Scientific Research, Grenoble, France.

F Sanz (F)

Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

M Tayeb (M)

Medicalchain, York Road, London, SQ1 7NQ, UK.
National Health Service, London, UK.

G Thomassen (G)

University of Oslo, Oslo, Norway.

J Van Bussel (J)

Scientific Institute of Public Health, Brussels, Belgium.

M Van den Bulcke (M)

Scientific Institute of Public Health, Brussels, Belgium.

H Van Oyen (H)

Department of Computer Science and Academic Computing Center Cyfronet, Akademia Gornizco Hutnizca University of Science and Technology, Krakow, Poland.
Sciensano, Juliette Wystmanstraat, 1050, Brussels, Belgium.

Articles similaires

Humans Resilience, Psychological Rhode Island Biomedical Research Stress, Psychological
United States Periodicals as Topic Cross-Sectional Studies Humans Biomedical Research
Humans Africa South of the Sahara Neoplasms Biomedical Research Male
Humans Pilot Projects Students, Medical Education, Medical, Undergraduate Turkey

Classifications MeSH